Jenny is a versatile life sciences patent attorney and IP adviser who represents US and international clients in a wide array of patent-related matters. She draws on an in-depth understanding of her clients’ industries and technology to help them protect innovations involving antibodies, cell therapies, gene editing, small molecule therapeutics, pharmaceutical formulations, and diagnostic agents and assays.
Jenny’s practice encompasses US and international patent prosecution, IP due diligence for transactions, clearance analyses, licensing, opinion work, and post-grant proceedings. She has extensive experience with providing strategic counseling on the life-cycle management of both biological and small molecule products.
Prior to joining Mintz, Jenny practiced patent law for more than 15 years, most recently as a partner at an international law firm.
Earlier in her career, as a Harvard Medical School postdoctoral fellow, she worked in the laboratory of Dr. David Hafler at Brigham & Women’s Hospital. In that role, she conducted research on T cell activity in autoimmune diseases such as Type I diabetes.
Experience
- Built global patent portfolios covering an antibody product for a multinational pharmaceutical company that obtained marketing approval in various countries.
- Built global patent portfolios covering cell therapy products for a leading gene editing company.
- Conducted a clearance analysis in connection with a multinational pharmaceutical company’s biosimilar drug development.
- Conducted due diligence studies in connection with various biotech transactions.
- Assisted a leading academic institution in securing patent protection for a diagnostic test expected to be used on millions of patients to ascertain risks for adverse drug reactions.
- Demonstrated continuous diligence over an 11-month period in an interference proceeding for a publicly traded biotechnology company.
viewpoints
News & Press
Mintz Announces Record Member Growth in 2023
December 22, 2023
Mintz Adds IP Partner From McDermott In Boston
October 26, 2023
Events & Speaking
Recognition & Awards
The Legal 500 United States (2021)
Best Lawyers in America: Patent Law (2022 – 2023)
Massachusetts Super Lawyers: Rising Star – Intellectual Property (2014 – 2016)
Identified in the IAM Patent 1000 for Prosecution (2021– 2023)
Involvement
- Member, American Bar Association
- Member, American Intellectual Property Law Association
- Member, Boston Patent Law Association